Literature DB >> 7606187

Reactive oxygen species in the killing of Pseudomonas aeruginosa by human leukocytes.

J P Mizgerd1, J D Brain.   

Abstract

Pseudomonas aeruginosa (PA) infects hosts with compromised host defenses. An important defense mechanism is the generation of reactive oxygen species (ROS) by white blood cells (WBCs). What roles do ROS play in host defense against PA? Human WBCs killed PA in vitro, and they generated a respiratory burst as measured by the production of H2O2. ROS efficiently killed PA; in acellular assays, less than 10 mM of H2O2 or OCl- eliminated all bacteria in 90 min. However, WBCs with suppressed production of ROS (caused by hypoxia) killed PA normally. In addition, none of the antioxidants vitamin C, N-acetylcysteine, superoxide dismutase, or catalase affected PA killing by WBCs. Thus, PA stimulates WBCs to produce ROS, which can kill the bacteria, but disturbances of WBC ROS production do not interfere with the killing of PA. WBCs have robust, redundant mechanisms for PA elimination.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606187     DOI: 10.1007/BF00294288

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  11 in total

1.  Oxidative metabolism in the alveolar macrophage: analysis by flow cytometry.

Authors:  L Kobzik; J J Godleski; J D Brain
Journal:  J Leukoc Biol       Date:  1990-04       Impact factor: 4.962

2.  Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms.

Authors:  E T Jensen; A Kharazmi; K Lam; J W Costerton; N Høiby
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils.

Authors:  G L Mandell
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

4.  Granule enzymes of polymorphonuclear neutrophils: A phylogenetic comparison.

Authors:  P G Rausch; T G Moore
Journal:  Blood       Date:  1975-12       Impact factor: 22.113

5.  Comparison of granule proteins from human polymorphonuclear leukocytes which are bactericidal toward Pseudomonas aeruginosa.

Authors:  K R Wasiluk; K M Skubitz; B H Gray
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  The effect of human alveolar macrophages on the bactericidal capacity of neutrophils.

Authors:  J E Pennington; T H Rossing; L W Boerth
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

7.  Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes.

Authors:  S E Malawista; R R Montgomery; G van Blaricom
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Role of the phagocyte in host-parasite interactions. XI. Relationship between stimulated oxidative metabolism and hydrogen peroxide formation, and intracellular killing.

Authors:  R J McRipley; A J Sbarra
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

9.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less.

Authors:  L Johnson; F W Bowen; S Abbasi; N Herrmann; M Weston; L Sacks; R Porat; G Stahl; G Peckham; M Delivoria-Papadopoulos
Journal:  Pediatrics       Date:  1985-04       Impact factor: 7.124

View more
  8 in total

1.  Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).

Authors:  H Yu; J C Boucher; N S Hibler; V Deretic
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  The transcriptional regulator AlgR is essential for Pseudomonas aeruginosa pathogenesis.

Authors:  Stephen E Lizewski; Derek S Lundberg; Michael J Schurr
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.

Authors:  M Allewelt; F T Coleman; M Grout; G P Priebe; G B Pier
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Antioxidant enzyme expression in clinical isolates of Pseudomonas aeruginosa: identification of an atypical form of manganese superoxide dismutase.

Authors:  B E Britigan; R A Miller; D J Hassett; M A Pfaller; M L McCormick; G T Rasmussen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Effect of partial liquid ventilation on bacterial clearance during Pseudomonas aeruginosa-induced lung injury in rats.

Authors:  Saïda Rezaiguia-Delclaux; Kun Yang; François Stephan; François Lemaire; Michel Meignan; Alain Harf; Philippe Duvaldestin; Christophe Delclaux
Journal:  Intensive Care Med       Date:  2003-05-24       Impact factor: 17.440

6.  Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation.

Authors:  Kun Yang; Elie Azoulay; Lynda Attalah; Jean-Ralph Zahar; Andry Van de Louw; Charles Cerf; Claude-James Soussy; Philippe Duvaldestin; Laurent Brochard; Christian Brun-Buisson; Alain Harf; Christophe Delclaux
Journal:  Intensive Care Med       Date:  2003-01-23       Impact factor: 17.440

Review 7.  Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis.

Authors:  Benoît S Marteyn; Pierre-Régis Burgel; Laurent Meijer; Véronique Witko-Sarsat
Journal:  Front Cell Infect Microbiol       Date:  2017-06-30       Impact factor: 5.293

Review 8.  Competitive Cell Death Interactions in Pulmonary Infection: Host Modulation Versus Pathogen Manipulation.

Authors:  Ethan S FitzGerald; Nivea F Luz; Amanda M Jamieson
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.